Free Trial
NASDAQ:IMNN

Imunon (IMNN) Stock Price, News & Analysis

Imunon logo
$0.79 -0.01 (-1.13%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$0.80 +0.01 (+0.63%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Imunon Stock (NASDAQ:IMNN)

Key Stats

Today's Range
$0.77
$0.82
50-Day Range
$0.40
$2.67
52-Week Range
$0.37
$3.65
Volume
474,294 shs
Average Volume
3.70 million shs
Market Capitalization
$13.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50
Consensus Rating
Moderate Buy

Company Overview

Imunon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

IMNN MarketRank™: 

Imunon scored higher than 42% of companies evaluated by MarketBeat, and ranked 629th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Imunon has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Imunon has only been the subject of 2 research reports in the past 90 days.

  • Read more about Imunon's stock forecast and price target.
  • Earnings Growth

    Earnings for Imunon are expected to grow in the coming year, from ($1.68) to ($1.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Imunon is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Imunon is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Imunon has a P/B Ratio of 2.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Imunon's valuation and earnings.
  • Percentage of Shares Shorted

    22.32% of the float of Imunon has been sold short.
  • Short Interest Ratio / Days to Cover

    Imunon has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Imunon has recently decreased by 22.50%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Imunon does not currently pay a dividend.

  • Dividend Growth

    Imunon does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    22.32% of the float of Imunon has been sold short.
  • Short Interest Ratio / Days to Cover

    Imunon has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Imunon has recently decreased by 22.50%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Imunon has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Imunon this week, compared to 2 articles on an average week.
  • Search Interest

    Only 16 people have searched for IMNN on MarketBeat in the last 30 days. This is a decrease of -16% compared to the previous 30 days.
  • MarketBeat Follows

    Only 6 people have added Imunon to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Imunon insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.96% of the stock of Imunon is held by insiders.

  • Percentage Held by Institutions

    Only 4.47% of the stock of Imunon is held by institutions.

  • Read more about Imunon's insider trading history.
Receive IMNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter.

IMNN Stock News Headlines

Imunon, Inc. (IMNN) - Yahoo Finance
Wall Street Zen Upgrades Imunon (NASDAQ:IMNN) to Hold
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
IMNN: Translational Data from OVATION 2 Presented…
See More Headlines

IMNN Stock Analysis - Frequently Asked Questions

Imunon's stock was trading at $0.95 at the beginning of the year. Since then, IMNN stock has decreased by 16.7% and is now trading at $0.7910.

Imunon, Inc. (NASDAQ:IMNN) announced its quarterly earnings results on Monday, May, 12th. The company reported ($0.28) earnings per share for the quarter, beating analysts' consensus estimates of ($0.35) by $0.07.
Read the conference call transcript
.

Shares of IMNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imunon investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Energy Transfer (ET), NVIDIA (NVDA), AT&T (T), AbbVie (ABBV) and Broadcom (AVGO).

Company Calendar

Last Earnings
5/12/2025
Today
7/05/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMNN
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.50
High Stock Price Target
$17.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+1,859.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.62 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$500 thousand
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
2.73

Miscellaneous

Free Float
16,496,000
Market Cap
$13.87 million
Optionable
Not Optionable
Beta
1.93
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:IMNN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners